Stem Cell Therapy for Crohn’s Fistulas Shows Benefits in Phase 3 Trial – IBD News Today
IBD News Today |
Stem Cell Therapy for Crohn's Fistulas Shows Benefits in Phase 3 Trial
IBD News Today Patients with Crohn's disease often exhibit complex perianal fistulas for which there are limited treatment options. The investigational agent Cx601 is a suspension of allogenic adipose-derived stem cells (eASC) that are being developed to treat these … |
